Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Go back to Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
(NASDAQ: ACON) Delayed: 2.45 --0 (-0%)
Previous Close $2.45    52 Week High
Open $2.45    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.45    EPS
Volume 1,254       

(NASDAQ: ACONW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High
Open $0.02    52 Week Low
Day High $0.02    P/E N/A 
Day Low $0.02    EPS
Volume 1,254